Frozen in Translation: Biobanks as a Tool for Cancer Research
DOI:
https://doi.org/10.6000/2292-2598.2015.03.02.2Keywords:
Biobank, tumor bank, frozen tissue, biological fluids, clinical samples, informed consentAbstract
In the context of translational cancer research, biobanks are key infrastructures that provide high quality biological samples, coupled with relevant clinical and pathological information. This role can only be successfully accomplished through the implementation of standardized procedures that ensure proper collection, handling, processing, storage and recording of tissue samples, following strict legal and ethical regulations. Biobank networking is fundamental for dissemination of good practices and to help in the establishment of new infrastructures that improve the assessment of heterogeneity among tumor types and across patient cohorts. Growing demands for large number of homogenously preserved tumor tissue samples can only be met through a more intense cooperation among biobanks, facilitated by networks that foster cooperation at international level. The potential of biobanks as fundamental tools for translational cancer research can only be achieved through a concerted effort from biobankers, researchers, legislators and tissue donors that may allow for improved sample exchange.
References
Campbell LD, Betsou F, Garcia DL, Giri JG, Pitt KE, Pugh RS, et al. Development of the ISBER Best Practices for Repositories: Collection, Storage, Retrieval and Distribution of Biological Materials for Research. Biopreservation and biobanking 2012; 10(2): 232-3. http://dx.doi.org/10.1089/bio.2012.1025 DOI: https://doi.org/10.1089/bio.2012.1025
Huang J, Qi R, Quackenbush J, Dauway E, Lazaridis E, Yeatman T. Effects of ischemia on gene expression. J Surg Res 2001; 99(2): 222-7. http://dx.doi.org/10.1006/jsre.2001.6195 DOI: https://doi.org/10.1006/jsre.2001.6195
Morente MM, Mager R, Alonso S, Pezzella F, Spatz A, Knox K, et al. TuBaFrost 2: Standardising tissue collection and quality control procedures for a European virtual frozen tissue bank network. Eur J Cancer 2006; 42(16): 2684-91. http://dx.doi.org/10.1016/j.ejca.2006.04.029 DOI: https://doi.org/10.1016/j.ejca.2006.04.029
Common minimum technical standards and Protocols for biological resource centres dedicated to cancer research. IARC : Working Group Reports 2007.
Qualman SJ, France M, Grizzle WE, LiVolsi VA, Moskaluk CA, Ramirez NC, et al. Establishing a tumour bank: banking, informatics and ethics. Br J Cancer 2004; 90(6): 1115-9. http://dx.doi.org/10.1038/sj.bjc.6601678 DOI: https://doi.org/10.1038/sj.bjc.6601678
NCI Best Practices for Biospecimen Resources; Office of Biorepositories and Biospecimen Research National Cancer Institute National Institutes of Health U.S. Department of Health and Human Services 2011 [updated 28/7/2014]; Available from: http: //biospecimens.cancer.gov/practices/
Spruessel A, Steimann G, Jung M, Lee SA, Carr T, Fentz AK, et al. Tissue ischemia time affects gene and protein expression patterns within minutes following surgical tumor excision. Biotechniques 2004; 36(6): 1030-7. DOI: https://doi.org/10.2144/04366RR04
Dash A, Maine IP, Varambally S, Shen R, Chinnaiyan AM, Rubin MA. Changes in differential gene expression because of warm ischemia time of radical prostatectomy specimens. Am J Pathol 2002; 161(5): 1743-8. http://dx.doi.org/10.1016/S0002-9440(10)64451-3 DOI: https://doi.org/10.1016/S0002-9440(10)64451-3
Blackhall FH, Pintilie M, Wigle DA, Jurisica I, Liu N, Radulovich N, et al. Stability and heterogeneity of expression profiles in lung cancer specimens harvested following surgical resection. Neoplasia 2004; 6(6): 761-7. http://dx.doi.org/10.1593/neo.04301 DOI: https://doi.org/10.1593/neo.04301
Musella V, Verderio P, Reid JF, Pizzamiglio S, Gariboldi M, Callari M, et al. Effects of warm ischemic time on gene expression profiling in colorectal cancer tissues and normal mucosa. PLoS One 2013; 8(1): e53406. DOI: https://doi.org/10.1371/journal.pone.0053406
Condelli V, Lettini G, Patitucci G, D'Auria F, D'Amico M, Vita G, et al. Validation of vacuum-based refrigerated system for biobanking tissue preservation: analysis of cellular morphology, protein stability, and RNA quality. Biopreservation and biobanking 2014; 12(1): 35-45. http://dx.doi.org/10.1089/bio.2013.0065 DOI: https://doi.org/10.1089/bio.2013.0065
Hogman CF, Meryman HT. Storage parameters affecting red blood cell survival and function after transfusion. Transfusion medicine reviews 1999; 13(4): 275-96. http://dx.doi.org/10.1016/S0887-7963(99)80058-3 DOI: https://doi.org/10.1016/S0887-7963(99)80058-3
Holland NT, Smith MT, Eskenazi B, Bastaki M. Biological sample collection and processing for molecular epidemiological studies. Mutat Res 2003; 543(3): 217-34. http://dx.doi.org/10.1016/S1383-5742(02)00090-X DOI: https://doi.org/10.1016/S1383-5742(02)00090-X
Diagnostic samples: From the patient to the laboratory The impact of preanalytical variables on the quality of laboratory results. 4th ed. Walter G. Guder SN, Hermann Wisser and Bernd Zawta, editor: Wiley-Blackwell Ed.; 2009.
Steinberg KK, Sanderlin KC, Ou CY, Hannon WH, McQuillan GM, Sampson EJ. DNA banking in epidemiologic studies. Epidemiologic reviews 1997; 19(1): 156-62. http://dx.doi.org/10.1093/oxfordjournals.epirev.a017938 DOI: https://doi.org/10.1093/oxfordjournals.epirev.a017938
Shabihkhani M, Lucey GM, Wei B, Mareninov S, Lou JJ, Vinters HV, et al. The procurement, storage, and quality assurance of frozen blood and tissue biospecimens in pathology, biorepository, and biobank settings. Clin Biochem 2014; 47(4-5): 258-66. http://dx.doi.org/10.1016/j.clinbiochem.2014.01.002 DOI: https://doi.org/10.1016/j.clinbiochem.2014.01.002
Isa K, Yamauchi MS, Nago TT, Yamane N. [Quantitative estimation of preanalytical variables which may influence the determinations of prothrombin time (PT) and activated partial thromboplastin time (APTT)]. Rinsho Byori 2010; 58(10): 979-85.
Wendland AE, Camargo JL, Polanczyk CA. Effect of preanalytical variables on myeloperoxidase levels. Clin Chim Acta 2010; 411(21-22): 1650-5. http://dx.doi.org/10.1016/j.cca.2010.06.015 DOI: https://doi.org/10.1016/j.cca.2010.06.015
Glasel JA. Validity of nucleic acid purities monitored by 260nm/280nm absorbance ratios. Biotechniques 1995; 18(1): 62-3.
Jewell SD, Srinivasan M, McCart LM, Williams N, Grizzle WH, LiVolsi V, et al. Analysis of the molecular quality of human tissues: an experience from the Cooperative Human Tissue Network. Am J Clin Pathol 2002; 118(5): 733-41. http://dx.doi.org/10.1309/VPQL-RT21-X7YH-XDXK DOI: https://doi.org/10.1309/VPQL-RT21-X7YH-XDXK
Imbeaud S, Graudens E, Boulanger V, Barlet X, Zaborski P, Eveno E, et al. Towards standardization of RNA quality assessment using user-independent classifiers of microcapillary electrophoresis traces. Nucleic Acids Res 2005; 33(6): e56. http://dx.doi.org/10.1093/nar/gni054 DOI: https://doi.org/10.1093/nar/gni054
Fleige S, Pfaffl MW. RNA integrity and the effect on the real-time qRT-PCR performance. Molecular aspects of medicine 2006; 27(2-3): 126-39. http://dx.doi.org/10.1016/j.mam.2005.12.003 DOI: https://doi.org/10.1016/j.mam.2005.12.003
Smith PK, Krohn RI, Hermanson GT, Mallia AK, Gartner FH, Provenzano MD, et al. Measurement of protein using bicinchoninic acid. Anal Biochem 1985; 150(1): 76-85. http://dx.doi.org/10.1016/0003-2697(85)90442-7 DOI: https://doi.org/10.1016/0003-2697(85)90442-7
Le Page C, Kobel M, de Ladurantaye M, Rahimi K, Madore J, Babinszky S, et al. Specimen quality evaluation in Canadian biobanks participating in the COEUR repository. Biopreservation and biobanking 2013; 11(2): 83-93. http://dx.doi.org/10.1089/bio.2012.0044 DOI: https://doi.org/10.1089/bio.2012.0044
Betsou F, Barnes R, Burke T, Coppola D, Desouza Y, Eliason J, et al. Human biospecimen research: experimental protocol and quality control tools. Cancer Epidemiol Biomarkers Prev 2009; 18(4): 1017-25. http://dx.doi.org/10.1158/1055-9965.EPI-08-1231 DOI: https://doi.org/10.1158/1055-9965.EPI-08-1231
Knoppers BM, Chadwick R. Human genetic research: emerging trends in ethics. Nat Rev Genet 2005; 6(1): 75-9. http://dx.doi.org/10.1038/nrg1505 DOI: https://doi.org/10.1038/nrg1505
Cambon-Thomsen A, Rial-Sebbag E, Knoppers BM. Trends in ethical and legal frameworks for the use of human biobanks. Eur Respir J 2007; 30(2): 373-82. http://dx.doi.org/10.1183/09031936.00165006 DOI: https://doi.org/10.1183/09031936.00165006
Budimir D, Polasek O, Marusic A, Kolcic I, Zemunik T, Boraska V, et al. Ethical aspects of human biobanks: a systematic review. Croatian medical journal 2011; 52(3): 262-79. http://dx.doi.org/10.3325/cmj.2011.52.262 DOI: https://doi.org/10.3325/cmj.2011.52.262
AM C. Legal and regulatory standards of informed consent in research. . In: Emanuel EJ GC, Crouch RA, Lie RK, Miller FG, Wendler D,, editor. Oxford textbook of clinical research ethics. Oxford: Oxford University Press; 2008. p. 613-32. DOI: https://doi.org/10.1093/oso/9780195168655.003.0058
Forsberg JS, Hansson MG, Eriksson S. The risks and benefits of re-consent. Science 2011; 332(6027): 306. http://dx.doi.org/10.1126/science.332.6027.306-a DOI: https://doi.org/10.1126/science.332.6027.306-a
Stein DT, Terry SF. Reforming biobank consent policy: a necessary move away from broad consent toward dynamic consent. Genetic testing and molecular biomarkers 2013; 17(12): 855-6. http://dx.doi.org/10.1089/gtmb.2013.1550 DOI: https://doi.org/10.1089/gtmb.2013.1550
Gornick MC, Ryan KA, Kim SY. Impact of non-welfare interests on willingness to donate to biobanks: an experimental survey. Journal of empirical research on human research ethics: JERHRE 2014; 9(4): 22-33. http://dx.doi.org/10.1177/1556264614544277 DOI: https://doi.org/10.1177/1556264614544277
Nobile H, Vermeulen E, Thys K, Bergmann MM, Borry P. Why do participants enroll in population biobank studies? A systematic literature review. Expert review of molecular diagnostics 2013; 13(1): 35-47. http://dx.doi.org/10.1586/erm.12.116 DOI: https://doi.org/10.1586/erm.12.116
Ormond KE, Cirino AL, Helenowski IB, Chisholm RL, Wolf WA. Assessing the understanding of biobank participants. Am J Med Genet A 2009; 149A(2): 188-98. http://dx.doi.org/10.1002/ajmg.a.32635 DOI: https://doi.org/10.1002/ajmg.a.32635
Gertz R. Withdrawing from participating in a biobank--a comparative study. European journal of health law 2008; 15(4): 381-9. http://dx.doi.org/10.1163/157180908X338269 DOI: https://doi.org/10.1163/157180908X338269
Hansson MG. The need to downregulate: a minimal ethical framework for biobank research. Methods Mol Biol 2011; 675: 39-59. http://dx.doi.org/10.1007/978-1-59745-423-0_2 DOI: https://doi.org/10.1007/978-1-59745-423-0_2
van Veen EB, Riegman PH, Dinjens WN, Lam KH, Oomen MH, Spatz A, et al. TuBaFrost 3: regulatory and ethical issues on the exchange of residual tissue for research across Europe. Eur J Cancer 2006; 42(17): 2914-23. http://dx.doi.org/10.1016/j.ejca.2006.04.028 DOI: https://doi.org/10.1016/j.ejca.2006.04.028
Eriksson S, Helgesson G. Potential harms, anonymization, and the right to withdraw consent to biobank research. Eur J Hum Genet 2005; 13(9): 1071-6. http://dx.doi.org/10.1038/sj.ejhg.5201458 DOI: https://doi.org/10.1038/sj.ejhg.5201458
Kaufman DJ, Murphy-Bollinger J, Scott J, Hudson KL. Public opinion about the importance of privacy in biobank research. Am J Hum Genet 2009; 85(5): 643-54. http://dx.doi.org/10.1016/j.ajhg.2009.10.002 DOI: https://doi.org/10.1016/j.ajhg.2009.10.002
Murphy J, Scott J, Kaufman D, Geller G, LeRoy L, Hudson K. Public perspectives on informed consent for biobanking. Am J Public Health 2009; 99(12): 2128-34. http://dx.doi.org/10.2105/AJPH.2008.157099 DOI: https://doi.org/10.2105/AJPH.2008.157099
Wolf SM, Annas GJ, Elias S. Point-counterpoint. Patient autonomy and incidental findings in clinical genomics. Science 2013; 340(6136): 1049-50. http://dx.doi.org/10.1126/science.1239119 DOI: https://doi.org/10.1126/science.1239119
Johnsson L, Helgesson G, Rafnar T, Halldorsdottir I, Chia KS, Eriksson S, et al. Hypothetical and factual willingness to participate in biobank research. Eur J Hum Genet 2010; 18(11): 1261-4. http://dx.doi.org/10.1038/ejhg.2010.106 DOI: https://doi.org/10.1038/ejhg.2010.106
Engels EM. Biobanks as basis for personalised nutrition? Mapping the ethical issues. Genes & nutrition 2007; 2(1): 59-62. http://dx.doi.org/10.1007/s12263-007-0006-9 DOI: https://doi.org/10.1007/s12263-007-0006-9
Cadigan RJ, Lassiter D, Haldeman K, Conlon I, Reavely E, Henderson GE. Neglected ethical issues in biobank management: Results from a U.S. study. Life sciences, society and policy 2013; 9(1): 1. http://dx.doi.org/10.1186/2195-7819-9-1 DOI: https://doi.org/10.1186/2195-7819-9-1
Data storage and DNA banking for biomedical research: technical, social and ethical issues. Eur J Hum Genet 2003; 11 Suppl 2: S8-10. http://dx.doi.org/10.1038/sj.ejhg.5201115 DOI: https://doi.org/10.1038/sj.ejhg.5201115
Cambon-Thomsen A. The social and ethical issues of post-genomic human biobanks. Nat Rev Genet 2004; 5(11): 866-73. http://dx.doi.org/10.1038/nrg1473 DOI: https://doi.org/10.1038/nrg1473
Joly Y, Dove ES, Knoppers BM, Bobrow M, Chalmers D. Data sharing in the post-genomic world: the experience of the International Cancer Genome Consortium (ICGC) Data Access Compliance Office (DACO). PLoS Comput Biol 2012; 8(7): e1002549. http://dx.doi.org/10.1371/journal.pcbi.1002549 DOI: https://doi.org/10.1371/journal.pcbi.1002549
Ballantyne C. Report urges Europe to combine wealth of biobank data. Nat Med 2008; 14(7): 701. http://dx.doi.org/10.1038/nm0708-701a DOI: https://doi.org/10.1038/nm0708-701a
Yuille M, van Ommen GJ, Brechot C, Cambon-Thomsen A, Dagher G, Landegren U, et al. Biobanking for Europe. Briefings in bioinformatics 2008; 9(1): 14-24. http://dx.doi.org/10.1093/bib/bbm050 DOI: https://doi.org/10.1093/bib/bbm050
Virani AH, Longstaff H. Ethical Considerations in Biobanks: How a Public Health Ethics Perspective Sheds New Light on Old Controversies. Journal of genetic counseling 2014. DOI: https://doi.org/10.1007/s10897-014-9781-9
Downloads
Published
How to Cite
Issue
Section
